Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Research Square|September 16, 2024
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6- methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosisKandarp Joshi, Menglang Yuan, Keisuke Katsushima, et al.
Acta Neuropathologica Communications|August 28, 2024
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosisKandarp Joshi, Menglang Yuan, Keisuke Katsushima, et al.
Neurology|August 24, 2014
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarianne Labussière, Blandine Boisselier, Karima Mokhtari, et al.
Nucleic Acids Research|January 17, 2020
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicinIris Tanaka, Alina Chakraborty, Olivier Saulnier, et al.
Developmental Cell|August 6, 2024
A single-cell transcriptomic map of the developing Atoh1 lineage identifies neural fate decisions and neuronal diversity in the hindbrainJessica C Butts, Sih-Rong Wu, Mark A Durham, et al.
Research Square|August 14, 2023
Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastomaVikas Daggubati, Akshara Vykunta, Abrar Choudhury, et al.
Cell Reports|March 9, 2024
A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastomaKeisuke Katsushima, Kandarp Joshi, Menglang Yuan, et al.
Molecular Oncology|June 21, 2023
The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survivalShubin W Shahab, Christianna M Roggeveen, Jiarong Sun, et al.
Nature Communications|July 21, 2020
An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fateJamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison, et al.
Communications Biology|July 14, 2022
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progressionJamie Zagozewski, Stephanie Borlase, Brent J Guppy, et al.
Pageof 4